Elevated RIPK2 Expression in Atopic Dermatitis Skin Is Associated with Mixed Th1/Th2 Cytokine Responses in CD4+ T Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188253 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Raeda Mubariki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Proteomic Unit, Bnai-Zion Medical Center, Haifa 3339419, Israel. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Cytokines, Receptor-Interacting Protein Serine-Threonine Kinase 2, Th1 Cells. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Receptor-interacting protein kinase 2 (RIPK2) is a critical mediator of the immune system leading to production of pro-inflammatory cytokines. Its role in the pathogenesis of atopic dermatitis (AD) has not been defined. This work aims to assess RIPK2 expression in the skin in AD and to evaluate the association with Th1-, Th2-, and Th17-related cytokine expression in lesional skin. AD patients’ skin biopsies and healthy controls were collected. An OPAL multiplex immunohistochemistry method was used to simultaneously detect TNF-α, IL-4, IL-13 and IL-17 in CD4+ RIPK2+ and CD4+ RIPK2− T cells. Quantitative image analysis was performed, and group comparisons were made using non-parametric Mann–Whitney tests. Our results show that CD4+RIPK2+ cells were significantly abundant in AD skin, with mark increased expression of Th1, Th2, and Th17 cytokines simultaneously. However, CD4+ RIPK2− T cells in AD overexpress TNFa without elevated Th2 cytokines, and IL-17+ cells were only marginally increased. In conclusion RIPK2 expression is upregulated in infiltrating CD4+ T cells in AD skin, with a mixed Th1/Th2 cytokine profile, suggesting that enhanced RIPK2 signaling contributes to the immune dysregulation in adult AD. These findings identify RIPK2 as a potential marker of Th1/Th2-high immune endotypes in AD and as a possible therapeutic target for intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Proteomic Unit, Bnai-Zion Medical Center, Haifa 3339419, Israel.
- Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
- Department of Dermatology, Rambam Medical Campus, The Rappaport Faculty of Medicine, Haifa 3525433, Israel.
- Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus Givat-Ram, Jerusalem 9190401, Israel.
- The Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
- Allergy and Clinical Immunology, The Holy Family Hospital, Nazareth 1600934, Israel.
ORCID-Profile: Ziad Khamaysi, Eran Blacher
Zitieren
APA
Mubariki, R., Khamaysi, Z., Kaabour, E., Salih, M., Belity, T., Toubi, E., Blacher, E., & Vadasz, Z. (2026). Elevated RIPK2 Expression in Atopic Dermatitis Skin Is Associated with Mixed Th1/Th2 Cytokine Responses in CD4+ T Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188253
Vancouver
Mubariki R, Khamaysi Z, Kaabour E, Salih M, Belity T, Toubi E, et al. Elevated RIPK2 Expression in Atopic Dermatitis Skin Is Associated with Mixed Th1/Th2 Cytokine Responses in CD4+ T Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188253
BibTeX
@article{Mubariki2026,
author = {Mubariki, Raeda and Khamaysi, Ziad and Kaabour, Elie and Salih, Mishlab and Belity, Tal and Toubi, Elias and Blacher, Eran and Vadasz, Zahava},
title = {Elevated RIPK2 Expression in Atopic Dermatitis Skin Is Associated with Mixed Th1/Th2 Cytokine Responses in CD4+ T Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188253}
}
EUVIMED